In vivo nucleic acid delivery with PEI and its derivatives: Current status and perspectives

Expert Review of Medical Devices

Volumn 8, Issue 2, 2011, Pages 173-185

  Lai, Wing Fu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cationic polymers; in vivo; nonviral vector; nucleic acid delivery; poly(ethylenimine)

Indexed keywords

DISTILLATION; NUCLEIC ACIDS; STEM CELLS;

CATIONIC POLYMERS; IN-VIVO; NONVIRAL VECTORS; NUCLEIC ACID DELIVERIES; POLY(ETHYLENIMINE);

BIOMOLECULES;

DNA VACCINE; DRUG CARRIER; MELPHALAN; NUCLEIC ACID; POLYETHYLENEIMINE; POLYETHYLENEIMINE DERIVATIVE;

HUMAN; IN VIVO GENE TRANSFER; IN VIVO NUCLEIC ACID DELIVERY; INFLUENZA; NONHUMAN; REVIEW; RNA TRANSPORT; RNA VECTOR; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL TRANSPLANTATION; TUBERCULOSIS;

EID: 79952614101     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.10.83     Document Type: Review

References (153)

1. O'Connor L, Glynn B. Recent advances in the development of nucleic acid diagnostics. Expert Rev. Med. Devices 7(4), 529-539 (2010).
2. Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326(5954), 818-823 (2009).
3. Bank A, Dorazio R, Leboulch P. A Phase I/II clinical trial of b-globin gene therapy for b-thalassemia. Ann. NY Acad. Sci. 1054, 308-316 (2005). (Pubitemid 43031038)
4. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. 20 years of gene therapy for SCID. Nat. Immunol. 11(6), 457-460 (2010).
5. Ferrari S, Pettenazzo A, Garbati N, Zacchello F, Behr JP, Scarpa M. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Bba-Gene Struct. Expr. 1447(2-3), 219-225 (1999). (Pubitemid 29494993)
6. Fajac I, Briand P, Monsigny M, Midoux P. Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum. Gene Ther. 10(3), 395-406 (1999). (Pubitemid 29097318)
7. Olefsky JM. Diabetes: gene therapy for rats and mice. Nature 408(6811), 420-421 (2000).
8. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J. Control. Release 94(1), 1-14 (2004). (Pubitemid 37542373)
9. Lai WF, Lin MCM. Nucleic acid delivery with chitosan and its derivatives. J. Control. Release 134(3), 158-168 (2009).
10. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 60(15), 3989-3999 (2000). (Pubitemid 30636571)
11. Degreve B, Andrei G, Izquierdo M et al. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer. Gene Ther. 4(10), 1107-1114 (1997). (Pubitemid 27469942)
12. Mahan SD, Ireton GC, Knoeber C, Stoddard BL, Black ME. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng. Des. Sel. 17(8), 625-633 (2004). (Pubitemid 39665399)
13. Zhang HZ, Wang Y, Gao P et al. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells. Cancer Biol. Ther. 5(11), 1457-1461 (2006).
14. Jang JY, Choi Y, Jeon YK, Kim CW. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo. Breast Cancer Res. 10(1), R11 (2008).
15. Ojano-Dirain C, Glushakova LG, Zhong L et al. An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1a. Mol. Genet. Metab. 101(2-3), 183-191 (2010).
16. Gao LL, Wu BY, Wang MW et al. Construction of a gastric cancer related gene GCRG213-specific siRNA expression vector and its effect on gastric cancer cells in vitro. Zhonghua Zhong Liu Za Zhi 29(2), 84-88 (2007).
17. Pearson S, Jia HP, Kandachi K. China approves first gene therapy. Nat. Biotechnol. 22(1), 3-4 (2004).
18. Lehrman S. Virus treatment questioned after gene therapy death. Nature 401(6753), 517-518 (1999).
19. Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10(11), 935-940 (2003). (Pubitemid 36722427)
20. Cole A. Child in gene therapy programme develops leukaemia. Br. Med. J. 336(7634), 13-13 (2008).
21. Hargreaves S. Rules on gene therapy are tightened after-leukaemia alert. Br. Med. J. 325(7368), 791 (2002).
22. Gebhart CL, Kabanov AV. Evaluation of polyplexes as gene transfer agents. J. Control. Release 73(2-3), 401-416 (2001). (Pubitemid 32539266)
23. Piskin E. Stimuli-responsive polymers in gene delivery. Expert Rev. Med. Devices 2(4), 501-509 (2005) (Pubitemid 41015131)
24. Ramesan RM, Sharma CP. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev. Med. Devices 6(6), 665-676 (2009).
25. Lai WF, Lin MCM. Chemical derivatization of chitosan for plasmid DNA delivery: present and future. In:Chitin, Chitosan and Their Derivatives: Biological Activities and Industrial Applications . Kim SK (Ed.).CRC Press, FL, USA, 69-82 (2010).
26. Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J. Gene Med. 6(7), 769-776 (2004). (Pubitemid 40228093)
27. Boussif O, Lezoualch F, Zanta MA et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo: polyethylenimine. Proc. Natl Acad. Sci. USA 92(16), 7297-7301 (1995).
28. Bandyopadhyay P, Ma XM, Linehan-Stieers C, Kren BT, Steer CJ. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. J. Biol. Chem. 274(15), 10163-10172 (1999).
29. Liu Y, Nguyen J, Steele T, Merkel O, Kissel T. A new synthesis method and degradation of hyper-branched polyethylenimine grafted polycaprolactone block mono-methoxyl poly (ethylene glycol) copolymers (hy-PEI-g-PCL-b-mPEG) as potential DNA delivery vectors. Polymer 50(16), 3895-3904 (2009).
30. Aigner A, Fischer D, Merdan T, Brus C, Kissel T, Czubayko F. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther. 9(24), 1700-1707 (2002). (Pubitemid 36104614)
31. von Harpe A, Petersen H, Li YX, Kissel T. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J. Control. Release 69(2), 309-322 (2000).
32. Kunath K, von Harpe A, Fischer D et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Control. Release 89(1), 113-125 (2003). (Pubitemid 36412116)
33. Fischer D, Bieber T, Li YX, Elsasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 16(8), 1273-1279 (1999). (Pubitemid 29393618)
34. Lungwitz U, Breunig M, Blunk T, Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60(2), 247-266 (2005). (Pubitemid 40804565)
35. Zou SM, Erbacher P, Remy JS, Behr JP. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J. Gene Med. 2(2), 128-134 (2000).
36. Saegusa T, Ikeda H, Fujii H. Isomerization polymerization of 2-oxazoline. I. Preparation of unsubstituted 2-oxazoline polymer. Polym. J. 3(1), 35-39 (1972).
37. Weyts KF, Goethals EJ. New synthesis of linear polyethyleneimine. Polym. Bull. 19(1), 13-19 (1988).
38. Creusat G, Zuber G. Self-assembling polyethylenimine derivatives mediate efficient siRNA delivery in mammalian cells. Chembiochem. 9(17), 2787-2789 (2008).
39. Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E. Cell cycle dependence of gene transfer by lipoplex polyplex and recombinant adenovirus. Gene Ther. 7(5), 401-407 (2000). (Pubitemid 30156552)
40. Brunner S, Furtbauer E, Sauer T, Kursa M, Wagner E. Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol. Ther. 5(1), 80-86 (2002). (Pubitemid 34110484)
41. Wightman L, Kircheis R, Rossler V et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3(4), 362-372 (2001). (Pubitemid 33691776)
42. Goula D, Remy JS, Erbacher P et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther. 5(5), 712-717 (1998). (Pubitemid 28256824)
43. Grosse S, Thevenot G, Aron Y et al. In vivo gene delivery in the mouse lung with lactosylated polyethylenimine, questioning the relevance of in vitro experiments. J. Control. Release 132(2), 105-112 (2008).
44. Sun X, Zhang N. Cationic polymer optimization for efficient gene delivery. Mini Rev. Med. Chem. 10(2), 108-125 (2010).
45. Rudolph C, Ortiz A, Schillinger U, Jauernig J, Plank C, Rosenecker J. Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. J. Gene Med. 7(1), 59-66 (2005).
46. Min SH, Lee DC, Lim MJ et al. A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA. J. Gene Med. 8(12), 1425-1434 (2006). (Pubitemid 46040650)
47. Jeudy G, Salvadori F, Chauffert B, Solary E, Vabres P, Chluba J. Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth. Cancer Gene Ther. 15(11), 742-749 (2008).
48. Tada Y, Kitahara T, Yoshioka T et al. Partial hepatectomy enhances polyethylenimine-mediated plasmid DNA delivery. Biol. Pharm. Bull. 29(8), 1712-1716 (2006). (Pubitemid 44166377)
49. Kursa M, Walker GF, Roessler V et al. Novel shielded transferrin- polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug. Chem. 14(1), 222-231 (2003). (Pubitemid 36169036)
50. Kircheis R, Wightman L, Schreiber A et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8(1), 28-40 (2001). (Pubitemid 32162413)
51. Petersen H, Fechner PM, Martin AL et al. Polyethylenimine-graft- poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug. Chem. 13(4), 845-854 (2002). (Pubitemid 34801128)
52. Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M, Wagner E. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Release 91(1-2), 173-181 (2003). (Pubitemid 37288888)
53. Ahn CH, Chae SY, Bae YH, Kim SW. Biodegradable poly (ethylenimine) for plasmid DNA delivery. J. Control. Release 80(1-3), 273-282 (2002). (Pubitemid 34273765)
54. Tang GP, Zeng JM, Gao SJ et al. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent. Biomaterials 24(13), 2351-2362 (2003). (Pubitemid 36434055)
55. Nguyen HK, Lemieux P, Vinogradov SV et al. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7(2), 126-138 (2000). (Pubitemid 30088959)
56. Plank C, Mechtler K, Szoka FC, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7(12), 1437-1446 (1996). (Pubitemid 26293564)
57. Chumakova OV, Liopo AV, Andreev VG et al. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett. 261(2), 215-225 (2008).
58. Chen D, Liu Y, Lehtinen A et al. A novel nonviral gene delivery vector: low-molecular-weight polyethylenimine-graft- ovalbumin. J. Appl. Polym. 114(6), 3744-3750 (2009).
59. Di Gioia S, Rejman J, Carrabino S et al. Role of biophysical parameters on ex vivo and in vivo gene transfer to the airway epithelium by polyethylenimine/albumin complexes. Biomacromolecules 9(3), 859-866 (2008). (Pubitemid 351560476)
60. Jeon O, Yang HS, Lee TJ, Kim BS. Heparin-conjugated polyethylenimine for gene delivery. J. Control. Release 132(3), 236-242 (2008).
61. Jiang G, Min SH, Oh EJ, Hahn SK. DNA/PEI/alginate polyplex as an efficient in vivo gene delivery system. Appl. Biochem. Biotechnol. 12(6), 684-689 (2007).
62. Jiang G, Park K, Kim J, Kim KS, Hahn SK. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Mol. Pharm. 6(3), 727-737 (2009).
63. Kievit FM, Veiseh O, Bhattarai N et al. PEI-PEG-chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery: Synthesis, complexation, and transfection. Adv. Funct. Mater. 19(14), 2244-2251 (2009).
64. Merkel OM, Beyerle A, Librizzi D et al. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Mol. Pharm. 6(4), 1246-1260 (2009).
65. Chen J, Gao XL, Hu KL et al. Galactose-poly(ethylene glycol)- polyethylenimine for improved lung gene transfer. Biochem. Biophys. Res. Commun. 375(3), 378-383 (2008).
66. Kleemann E, Neu M, Jekel N et al. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J. Control. Release 109(1-3), 299-316 (2005). (Pubitemid 41737272)
67. Li D, Wang QQ, Tang GP et al. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface. J. Zhejiang Univ. Sci. B 7(11), 906-911 (2006).
68. Kichler A, Chillon M, Leborgne C, Danos O, Frisch B. Intranasal gene delivery with a polyethylenimine-PEG conjugate. J. Control. Release 81(3), 379-388 (2002). (Pubitemid 34607157)
69. Sung SJ, Min SH, Cho KY et al. Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol. Pharm. Bull. 26(4), 492-500 (2003). (Pubitemid 39663595)
70. Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27(24), 4356-4373 (2006). (Pubitemid 43674179)
71. Wong JY, Kuhl TL, Israelachvili JN, Mullah N, Zalipsky S. Direct measurement of a tethered ligand-receptor interaction potential. Science 275(5301), 820-822 (1997). (Pubitemid 27074880)
72. Gao X, Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 35(3), 1027-1036 (1996). (Pubitemid 26034590)
73. Vitiello L, Chonn A, Wasserman JD, Duff C, Worton RG. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Ther. 3(5), 396-404 (1996). (Pubitemid 26171337)
74. Hong K, Zheng W, Baker A, Papahadjopoulos D. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)- phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. 400(2), 233-237 (1997). (Pubitemid 27036328)
75. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29(24-25), 3477-3496 (2008).
76. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6(4), 595-605 (1999). (Pubitemid 29192668)
77. Kircheis R, Schuller S, Brunner S et al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. 1(2), 111-120 (1999). (Pubitemid 129631068)
78. Pannier AK, Wieland JA, Shea LD. Surface polyethylene glycol enhances substrate-mediated gene delivery by nonspecifically immobilized complexes. Acta Biomater. 4(1), 26-39 (2008). (Pubitemid 350131561)
79. Erbacher P, Bettinger T, Belguise-Valladier P et al. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI).J. Gene Med. 1(3), 210-222 (1999). (Pubitemid 129631076)
80. Burke RS, Pun SH. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug. Chem. 19(3), 693-704 (2008). (Pubitemid 351431402)
81. Mishra S, Webster P, Davis ME. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. Cell Biol. 83(3), 97-111 (2004). (Pubitemid 38765217)
82. Greenfield RS, Kaneko T, Daues A et al. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Cancer Res. 50(20), 6600-6607 (1990). (Pubitemid 20348786)
83. Tomlinson R, Heller J, Brocchini S, Duncan R. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjug. Chem. 14(6), 1096-1106 (2003). (Pubitemid 37449036)
84. Murthy N, Campbell J, Fausto N, Hoffman AS, Stayton PS. Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. J. Control. Release 89(3), 365-374 (2003). (Pubitemid 36555897)
85. Shin J, Shum P, Thompson DH. Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J. Control. Release 91(1-2), 187-200 (2003). (Pubitemid 37288890)
86. Lee M, Kim SW. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm. Res. 22(1), 1-10 (2005). (Pubitemid 40558140)
87. Huang YC, Riddle K, Rice KG, Mooney DJ. Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum. Gene Ther. 16(5), 609-617 (2005). (Pubitemid 40740928)
88. Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4).Gene Ther. 12(5), 418-426 (2005). (Pubitemid 40394294)
89. Bivas-Benita M, Lin MY, Bal SM et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine 27(30), 4010-4017 (2009).
90. Zhou XF, Liu B, Yu XH et al. Controlled release of PEI/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime/MVA boost regime. Eur. J. Pharm. Biopharm. 68(3), 589-595 (2008). (Pubitemid 351318217)
91. Zou WW, Zhang N. Research progress of PLGA nanoparticle as non-viral gene delivery system. Chemistry of Life 29(1), 120-124 (2009).
92. Sasaki H, Yoshida S, Kitahara T et al. Influence of disease stage on polyethylenimine-mediated plasmid DNA delivery in murine hepatitis. Int. J. Pharm. 318(1-2), 139-145 (2006). (Pubitemid 43963309)
93. Smrekar B, Wightman L, Wolschek MF et al. Tissue-dependent factors affect gene delivery to tumors in vivo. Gene Ther. 10(13), 1079-1088 (2003). (Pubitemid 36850230)
94. Liu YQ, Tao J, Li Y et al. Targeting hypoxia-inducible factor-1a with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth. Mol. Ther. 17(2), 269-277 (2009).
95. Rosenecker J, Huth S, Rudolph C. Gene therapy for cystic fibrosis lung disease: current status and future perspectives. Curr. Opin. Mol. Ther. 8(5), 439-445 (2006). (Pubitemid 44566785)
96. Di Gioia S, Conese M. Polyethylenimine-mediated gene delivery to the lung and therapeutic applications. Drug Des. Devel. Ther. 2, 163-188 (2008).
97. McLachlan G, Baker A, Tennant P et al. Optimizing aerosol gene delivery and expression in the ovine lung. Mol. Ther. 15(2), 348-354 (2007). (Pubitemid 46111885)
98. Davies LA, McLachlan G, Sumner-Jones SG et al. Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol. Ther. 16(7), 1283-1290 (2008). (Pubitemid 351866060)
99. Hess DR. Aerosol delivery devices in the treatment of asthma. Respir. Care 53(6), 699-723 (2008).
100. Turker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharm. World Sci. 26(3), 137-142 (2004). (Pubitemid 39012580)
101. Brime B, Ballesteros MP, Frutos P. Preparation and in vitro characterization of gelatin microspheres containing Levodopa for nasal administration. J. Microencapsul. 17(6), 777-784 (2000).
102. Sarkar MA. Drug metabolism in the nasal mucosa. Pharm. Res. 9(1), 1-9 (1992).
103. Dahl R, Mygind N. Anatomy, physiology and function of the nasal cavities in health and disease. Adv. Drug Deliv. Rev. 29(1-2), 3-12 (1998). (Pubitemid 28044084)
104. Iwai M, Harada Y, Tanaka S et al. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector. Biochem. Biophys. Res. Commun. 291(1), 48-54 (2002). (Pubitemid 34681136)
105. Kang Y, Zhang XY, Jiang W et al. Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC Cancer 9, 126 (2009).
106. Zhou X, Liu B, Yu X et al. Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine. J. Control. Release 121(3), 200-207 (2007). (Pubitemid 47214651)
107. Thomas M, Lu JJ, Ge Q, Zhang CC, Chen JZ, Klibanov AM. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl Acad. Sci. USA 102(16), 5679-5684 (2005). (Pubitemid 40559619)
108. Wang S, Ma N, Gao SJ, Yu H, Leong KW. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes. Mol. Ther. 3(5 Pt 1), 658-664 (2001). (Pubitemid 32509862)
109. Rudolph C, Lausier J, Naundorf S, Muller RH, Rosenecker J. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J. Gene Med. 2(4), 269-278 (2000).
110. Liao HW, Yau KW. In vivo gene delivery in the retina using polyethylenimine. Biotechniques 42(3), 285-286, 288 (2007).
111. Dames P, Ortiz A, Schillinger U et al. Aerosol gene delivery to the murine lung is mouse strain dependent. J. Mol. Med. 85(4), 371-378 (2007). (Pubitemid 46452253)
112. Chollet P, Favrot MC, Hurbin A, Coll JL. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med. 4(1), 84-91 (2002). (Pubitemid 40277159)
113. Moffatt S, Wiehle S, Cristiano RJ. Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13. Hum. Gene Ther. 16(1), 57-67 (2005). (Pubitemid 40250332)
114. Yang Y, Lo SL, Yang JY et al. Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials 30(29), 5767-5774 (2009).
115. Zamora-Avila DE, Zapata-Benavides P, Franco-Molina MA et al. WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth. Cancer Gene Ther. 16(12), 892-899 (2009).
116. Kuo CN, Yang LC, Wu PC, Kuo HK, Kuo CJ, Tai MH. Dehydrated form of plasmid expressing basic fibroblast growth factor-polyethylenimine complex is a novel and accurate method for gene transfer to the cornea. Curr. Eye Res. 30(11), 1015-1024 (2005).
117. Morris KV, Rossi JJ. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection. Hum. Gene Ther. 17(5), 479-486 (2006). (Pubitemid 43794487)
118. Check E. Cancer risk prompts US to curb gene therapy. Nature 422(6927), 7 (2003). (Pubitemid 36323271)
119. Gaspar HB, Bjorkegren E, Parsley K et al. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol. Ther. 14(4), 505-513 (2006). (Pubitemid 44339393)
120. Boztug K, Dewey RA, Klein C. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Curr. Opin. Mol. Ther. 8(5), 390-395 (2006). (Pubitemid 44566780)
121. Xu J, Qu J, Cao L et al. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J. Pathol. 214(4), 472-481 (2008). (Pubitemid 351340567)
122. Tang YL, Zhao Q, Zhang YC et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul. Pept. 117(1), 3-10 (2004). (Pubitemid 37548393)
123. Meinel L, Hofmann S, Betz O et al. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials 27(28), 4993-5002 (2006). (Pubitemid 43866922)
124. Ferreira E, Potier E, Logeart- Avramoglou D, Salomskaite-Davalgiene S, Mir LM, Petite H. Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther. 15(7), 537-544 (2008). (Pubitemid 351405094)
125. Kolodka TM, Garlick JA, Taichman LB. Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc. Natl Acad. Sci. USA 95(8), 4356-4361 (1998). (Pubitemid 28207916)
126. Vassalli G, Bueler H, Dudler J, von Segesser LK, Kappenberger L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int. J. Cardiol. 90(2-3), 229-238 (2003). (Pubitemid 37087882)
127. Klopper J, Lindenmaier W, Fiedler U, Mehlhorn A, Stark GB, Finkenzeller G. High efficient adenoviral-mediated VEGF and Ang-1 gene delivery into osteogenically differentiated human mesenchymal stem cells. Microvasc. Res. 75(1), 83-90 (2008). (Pubitemid 350266732)
128. Santoni de Sio F, Naldini L. Short-term culture of human CD34+ cells for lentiviral gene transfer. Methods Mol. Biol. 506, 59-70 (2009).
129. Gregory-Evans K, Chang F, Hodges MD, Gregory-Evans CY. Ex vivo gene therapy using intravitreal injection of GDNF-secreting mouse embryonic stem cells in a rat model of retinal degeneration. Mol. Vis. 15, 962-973 (2009).
130. Worsham DN, Schuesler T, von Kalle C, Pan D. In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector. Mol. Ther. 14(4), 514-524 (2006). (Pubitemid 44296095)
131. Pan D. In situ (in vivo) gene transfer into murine bone marrow stem cells. Methods Mol. Biol. 506, 159-169 (2009).
132. Lim JY, Park SH, Jeong CH et al. Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnol. 10, 38 (2010).
133. Madeira C, Mendes RD, Ribeiro SC et al. Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. J. Biomed. Biotechnol. 2010, 735349 (2010).
134. Santos JL, Oliveira H, Pandita D et al. Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J. Control. Release 144(1), 55-64 (2010).
135. Wang W, Li W, Ou L et al. Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients. J. Cell. Mol. Med. (2011) (In press).
136. Marwick C. FDA halts gene therapy trials after leukaemia case in France. BMJ 326(7382), 181 (2003).
137. Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev. 58(4), 467-486 (2006). (Pubitemid 43949425)
138. Banerjee P, Weissleder R, Bogdanov A Jr. Linear polyethyleneimine grafted to a hyperbranched poly(ethylene glycol)-like core: a copolymer for gene delivery. Bioconjug. Chem. 17(1), 125-131 (2006). (Pubitemid 43157593)
139. Zhang P, Zhang H, Hu SS, Chen LG, Wei YJ. Plasmid transfection of rat bone marrow mesenchymal stem cells by cationic lipid for gene-modified cell transplantation therapy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27(4), 504-508 (2005).
140. He S, Zhang D, Cheng F, Gong F, Guo Y. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression. Mol. Biol. Rep. 36(8), 2153-2163 (2009).
141. Folini M, Pennati M, Zaffaroni N. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets. Methods Mol. Biol. 487, 303-330 (2009).
142. Day TW, Safa AR. RNA interference in cancer: targeting the anti-apoptotic protein c-FLIP for drug discovery. Mini Rev. Med. Chem. 9(6), 741-748 (2009).
143. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)- complexed siRNA in vivo. Gene Ther. 12(5), 461-466 (2005). (Pubitemid 40394299)
144. Fröhlich T, Wagner E. Peptide- and polymer-based delivery of therapeutic RNA. Soft Matter 6(2), 226-234 (2010).
145. Bonnet ME, Erbacher P, Bolcato-Bellemin AL. Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm. Res. 25(12), 2972-2982 (2008).
146. Gonzalez H, Hwang SJ, Davis ME. New class of polymers for the delivery of macromolecular therapeutics. Bioconjug. Chem. 10(6), 1068-1074 (1999).
147. Wong HH, Lemoine NR. Novel therapies for pancreatic cancer: setbacks and progress. Future Oncol. 6(7), 1061-1064 (2010).
148. Davis ME. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm. 6(3), 659-668 (2009).
149. Hackam DG, Redelmeier DA. Translation of research evidence from animals to humans. JAMA 296(14), 1731-1732 (2006). (Pubitemid 44547792)
150. Perel P, Roberts I, Sena E et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. Br. Med. J. 334(7586), 197-200 (2007). (Pubitemid 46198100)
151. Langley G, Evans T, Holgate ST, Jones A. Replacing animal experiments: choices, chances and challenges. Bioessays 29(9), 918-926 (2007). (Pubitemid 47424901)
152. Thasler WE, Schlott T, Kalkuhl A et al. Human tissue for in vitro research as an alternative to animal experiments: a charitable 'honest broker' model to fulfil ethical and legal regulations and to protect research participants. Altern. Lab. Anim. 34(4), 387-392 (2006). (Pubitemid 44369440)
153. Beynen AC, Gärtner K, van Zutphen LFM. Standardization of animal experimentation. In:Principles of Laboratory Animal Science. van Zutphen LFM, Baumans V, Beynen AC (Eds).Elsevier, Amsterdam, The Netherlands, 103-110 (2003)